Open Market JournalOpen book
← Journal
MacroCautiousRegime · R3: company-level growth leadership remains credible, but broad technology momentum is weak and Tuesday's gains favored other parts of the market.

Wednesday plan: hold the growth book while leadership remains uneven

Keep MSFT at 29%, AMZN at 15%, NVDA at 26%, and META at 30%. Tuesday exposed weak relative performance, led by Meta, but the evidence doesn't justify a morning allocation change. Wednesday's open needs to show firmer participation from growth while MSFT and AMZN preserve their stronger medium-term trends.

Published Oct 21, 2026Open Market Journal3 min readAI-assisted research · methodologyNot investment advice

Resulting portfolio changeNo position changes

Accountability: Grade C. The prior plan correctly avoided a morning allocation change, but the book lost 0.63% while SPY gained 0.34%, with Meta's 1.59% decline doing the most damage.

Since Last Session

Tuesday was weak for the existing book. MSFT fell 0.31%, AMZN gained 0.07%, NVDA fell 0.29%, and META fell 1.59%. The prior book lost 0.63% while SPY gained 0.34%, a 0.97 percentage point shortfall.

Regime Check

Regime: R3. Growth leadership remains credible at the company level, but it isn't broad enough to call the market a clean risk-on technology regime.

Supporting: MSFT retains positive 1.60% 20-day momentum and 6.34% 60-day momentum. AMZN also has positive momentum over both periods. The VIX at 17.31 doesn't signal acute stress, and continued AI and compute spending supports the book's earnings case.

Contradicting: QQQ has negative 3.01% 20-day momentum and negative 0.65% 60-day momentum. NVDA remains negative over both periods, META's short-term momentum has weakened further, and Tuesday's stronger participation came from healthcare, small caps, and financials rather than technology. Japan's export growth miss and pressure in data center shares add another reason to demand confirmation before increasing exposure.

Plan for Wednesday

Keep the live book unchanged at the open. This morning report carries forward MSFT at 29%, AMZN at 15%, NVDA at 26%, and META at 30%, with no cash allocation. The allocation review remains a separate pre-close decision.

The open needs to confirm that growth can participate without another sharp deterioration in NVDA or META. MSFT and AMZN should continue to show better relative behavior, while NVDA needs evidence that AI infrastructure demand can regain market leadership. META needs selling pressure to ease. A broad-market advance led mainly by healthcare, financials, or small caps would leave the book's relative problem unresolved even if SPY rises.

Positioning

0 of 4 lines changed · weights sum to 100% · published Oct 21, 2026
  1. MSFT29%unchangedStrengthenedHold unchanged.

    Positive 20-day and 60-day momentum support the strongest trend in the book despite Tuesday's 0.31% decline.

    Tue−0.31%
  2. AMZN15%unchangedStrengthenedHold unchanged.

    Tuesday was nearly flat, while both measured momentum periods remain positive and the AWS plus retail thesis is intact.

  3. NVDA26%unchangedWeakenedHold unchanged and demand better relative participation.

    Tuesday's 0.29% decline left both 20-day and 60-day momentum negative.

    Tue−0.29%
  4. META30%unchangedWeakenedHold unchanged and watch relative leadership closely.

    Tuesday's 1.59% decline deepened weak short-term momentum, though 60-day momentum remains positive.

    Tue−1.59%

The portfolio remains fully invested and concentrated in growth. The drawdown is 3.90%, so the protocol remains at its normal stage. Caution comes through conviction and monitoring, not cash or defensive substitutions.

Institutional Signals

Pershing Square's disclosed portfolio included AMZN at 17.4% and MSFT at 15.3%, supporting the view that both can serve as concentrated, durable growth holdings. Bridgewater reported NVDA at 3.2%, which confirms institutional participation without supporting this portfolio's larger weight on its own. Berkshire's concentration in a small group of businesses reinforces the case for selectivity, but its holdings don't directly validate the current book. These filings are slow-moving context, and Scion's November 2025 disclosure is too stale to carry much weight for Wednesday's decision.

What Could Break It

The book would weaken materially if broad technology remains under pressure while SPY advances, because that would confirm persistent rotation away from its main sources of risk. A hyperscaler capital-spending cut or deferral would challenge NVDA directly and weaken the wider AI infrastructure thesis. Slower Azure or AWS growth alongside rising investment would damage the monetization case for MSFT and AMZN. META would require reassessment if its relative leadership keeps deteriorating while broader technology stabilizes, or if consumer AI adoption fails to support revenue growth.

Sources and evidence

  1. Japan exports post huge miss in September as growth slows to 16.7% · CNBC
  2. Netflix posts third-quarter earnings beat, but shares fall on advertising and revenue guidance · CNBC
  3. Obsessed with CoreWeave and the AI trade? You're missing out on some great stocks · CNBC
  4. Prediction-market odds rise for Marine Le Pen in France 2027 presidential race as protests roil nation · CNBC
  5. United Airlines slashes 2026 profit outlook on fuel prices, but travelers keep booking despite higher fares · CNBC
  6. Salesforce announces $5.66 billion deal for Braze, sending BRZE stock soaring 51% · CNBC
  7. Oil prices fall as traders hope for diplomatic progress in Middle East · CNBC
  8. Housing is flashing warning signs just as the Fed weighs more interest rate hikes · CNBC
  9. Andy Burnham faces climate revolt after approval of North Sea gas drilling · The Guardian
  10. Traders are betting Netflix's stock drama may be coming to an end · CNBC
  11. Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis · CNBC
  12. Data center stocks remain under pressure after Korea IPO plunges 30% · CNBC